X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Advance price notification: A transparency measure that fails patients

By Saumil Pandya and Emily Donaldson  |    March 29, 2018
Most transparency reforms aim to correct perceived misaligned incentives in the biopharmaceutical marketplace. However, many efforts to mandate information flow in the private market have serious...   Read More

New Let’s Talk About Cost ads highlight how copay accumulator programs could leave patients financially exposed

By Holly Campbell  |    March 27, 2018
Today, as part of the Let’s Talk About Cost campaign, PhRMA unveiled new advertisements highlighting how the use of copay accumulator programs by insurance companies and other middlemen could...   Read More

Video: How does the supply chain shape brand-name medicine prices?

By Holly Campbell  |    March 19, 2018
A medicine’s path from the biopharmaceutical company to the patient is complex and involves many entities across the biopharmaceutical supply chain. In fact, more than one-third of the initial...   Read More

4 Things to know about the IQVIA 2018 and Beyond: Outlook and Turning Points report

By Holly Campbell  |    March 13, 2018
We continue to see a deluge of data from government actuaries and pharmacy benefit managers (PBMs) showing a dramatic slowdown in medicine spending growth. Most recently, the IQVIA Institute for...   Read More

ICYMI – Two PBM reports show dramatic slowdown in medicine spending growth

By Holly Campbell  |    March 2, 2018
Newly released pharmacy benefit manager (PBM) data show medicine spending is growing at the slowest rate in years. After accounting for discounts and rebates negotiated with biopharmaceutical...   Read More

Copay coupons can help ease patients’ out-of-pocket costs

By Holly Campbell  |    February 16, 2018
Each year, middlemen, like pharmacy benefit managers (PBMs) and insurers, shift more of the costs of health care to patients. Ensuring patients have affordable access to their medicines is the top...   Read More

Oregon’s HB 4005 fails to deliver savings for patients

By Caitlin Carroll  |    February 14, 2018
Medicine costs are growing at the slowest rate in years, but it doesn’t feel that way to patients who are facing higher out-of-pocket costs for their health care across the board. Proposals like...   Read More

PhRMA launches new consumer-facing Let’s Talk About Cost website

By Holly Campbell  |    January 24, 2018
Today, as part of the Let’s Talk About Cost campaign, PhRMA launched LetsTalkAboutCost.org, a national consumer-facing website to provide consumers with easy-to-understand information about the...   Read More

NHE Data: Medicine spending grew just 1.3 percent in 2016

By Holly Campbell  |    December 12, 2017
According to new data from the National Health Expenditures (NHE), retail medicine spending grew just 1.3 percent in 2016, down from 9 percent in 2015. To put that in context, total spending for...   Read More

Video: What is a results-based contract?

By Katie Koziara  |    November 13, 2017
New medicines are revolutionizing how we fight disease, but too often patients have to fight to access innovative treatments. As part of the solution to this problem, biopharmaceutical companies...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates